Single dose of BNT162b2 mRNA vaccine against SARS-CoV2 induces neutralizing antibody and polyfunctional T-cell responses in patients with CML
Patrick Harrington, Katie J. Doores, Deepti Radia, Amy O’Reilly, Ho Pui Jeff Lam, Jeffrey Seow, Carl Graham, Thomas Lechmere, Donal McLornan, Richard Dillon, Yogita Shanmugharaj, Andreas Espehana, Claire Woodley, Jamie Saunders, Natalia Curto-Garcia, Jennifer O’Sullivan, Shahram Kordasti, Michael H. Malim, Claire Harrison, Hugues de Lavallade
doi: https://doi.org/10.1101/2021.04.15.21255482
Patrick Harrington
1Department of Clinical Haematology, Guy’s & St Thomas’ NHS Foundation Trust, London, U.K.
2School of Cancer and Pharmaceutical Science, King’s College London. London, U.K.
Katie J. Doores
3Department of Infectious Diseases, School of Immunology & Microbial Sciences, King’s College London, London, UK
Deepti Radia
1Department of Clinical Haematology, Guy’s & St Thomas’ NHS Foundation Trust, London, U.K.
Amy O’Reilly
1Department of Clinical Haematology, Guy’s & St Thomas’ NHS Foundation Trust, London, U.K.
Ho Pui Jeff Lam
1Department of Clinical Haematology, Guy’s & St Thomas’ NHS Foundation Trust, London, U.K.
Jeffrey Seow
3Department of Infectious Diseases, School of Immunology & Microbial Sciences, King’s College London, London, UK
Carl Graham
3Department of Infectious Diseases, School of Immunology & Microbial Sciences, King’s College London, London, UK
Thomas Lechmere
3Department of Infectious Diseases, School of Immunology & Microbial Sciences, King’s College London, London, UK
Donal McLornan
1Department of Clinical Haematology, Guy’s & St Thomas’ NHS Foundation Trust, London, U.K.
2School of Cancer and Pharmaceutical Science, King’s College London. London, U.K.
Richard Dillon
1Department of Clinical Haematology, Guy’s & St Thomas’ NHS Foundation Trust, London, U.K.
4Department of Medicine and Molecular Genetics, King’s College London, London. U.K.
Yogita Shanmugharaj
1Department of Clinical Haematology, Guy’s & St Thomas’ NHS Foundation Trust, London, U.K.
Andreas Espehana
1Department of Clinical Haematology, Guy’s & St Thomas’ NHS Foundation Trust, London, U.K.
Claire Woodley
1Department of Clinical Haematology, Guy’s & St Thomas’ NHS Foundation Trust, London, U.K.
Jamie Saunders
1Department of Clinical Haematology, Guy’s & St Thomas’ NHS Foundation Trust, London, U.K.
Natalia Curto-Garcia
1Department of Clinical Haematology, Guy’s & St Thomas’ NHS Foundation Trust, London, U.K.
Jennifer O’Sullivan
1Department of Clinical Haematology, Guy’s & St Thomas’ NHS Foundation Trust, London, U.K.
Shahram Kordasti
1Department of Clinical Haematology, Guy’s & St Thomas’ NHS Foundation Trust, London, U.K.
2School of Cancer and Pharmaceutical Science, King’s College London. London, U.K.
Michael H. Malim
3Department of Infectious Diseases, School of Immunology & Microbial Sciences, King’s College London, London, UK
Claire Harrison
1Department of Clinical Haematology, Guy’s & St Thomas’ NHS Foundation Trust, London, U.K.
2School of Cancer and Pharmaceutical Science, King’s College London. London, U.K.
Hugues de Lavallade
1Department of Clinical Haematology, Guy’s & St Thomas’ NHS Foundation Trust, London, U.K.
2School of Cancer and Pharmaceutical Science, King’s College London. London, U.K.
5Department of Haematological Medicine, King’s College London School of Medicine, London, UK
Data Availability
Data available within the article or its supplementary materials
Posted April 22, 2021.
Single dose of BNT162b2 mRNA vaccine against SARS-CoV2 induces neutralizing antibody and polyfunctional T-cell responses in patients with CML
Patrick Harrington, Katie J. Doores, Deepti Radia, Amy O’Reilly, Ho Pui Jeff Lam, Jeffrey Seow, Carl Graham, Thomas Lechmere, Donal McLornan, Richard Dillon, Yogita Shanmugharaj, Andreas Espehana, Claire Woodley, Jamie Saunders, Natalia Curto-Garcia, Jennifer O’Sullivan, Shahram Kordasti, Michael H. Malim, Claire Harrison, Hugues de Lavallade
medRxiv 2021.04.15.21255482; doi: https://doi.org/10.1101/2021.04.15.21255482
Single dose of BNT162b2 mRNA vaccine against SARS-CoV2 induces neutralizing antibody and polyfunctional T-cell responses in patients with CML
Patrick Harrington, Katie J. Doores, Deepti Radia, Amy O’Reilly, Ho Pui Jeff Lam, Jeffrey Seow, Carl Graham, Thomas Lechmere, Donal McLornan, Richard Dillon, Yogita Shanmugharaj, Andreas Espehana, Claire Woodley, Jamie Saunders, Natalia Curto-Garcia, Jennifer O’Sullivan, Shahram Kordasti, Michael H. Malim, Claire Harrison, Hugues de Lavallade
medRxiv 2021.04.15.21255482; doi: https://doi.org/10.1101/2021.04.15.21255482
Subject Area
Subject Areas
- Addiction Medicine (399)
- Allergy and Immunology (708)
- Anesthesia (201)
- Cardiovascular Medicine (2931)
- Dermatology (249)
- Emergency Medicine (439)
- Epidemiology (12734)
- Forensic Medicine (12)
- Gastroenterology (827)
- Genetic and Genomic Medicine (4578)
- Geriatric Medicine (417)
- Health Economics (729)
- Health Informatics (2914)
- Health Policy (1069)
- Hematology (388)
- HIV/AIDS (924)
- Medical Education (424)
- Medical Ethics (115)
- Nephrology (468)
- Neurology (4345)
- Nursing (236)
- Nutrition (638)
- Oncology (2266)
- Ophthalmology (645)
- Orthopedics (258)
- Otolaryngology (324)
- Pain Medicine (279)
- Palliative Medicine (83)
- Pathology (500)
- Pediatrics (1196)
- Primary Care Research (495)
- Public and Global Health (6932)
- Radiology and Imaging (1526)
- Respiratory Medicine (915)
- Rheumatology (437)
- Sports Medicine (385)
- Surgery (487)
- Toxicology (60)
- Transplantation (210)
- Urology (180)